NULASTA Trademark

Trademark Overview

On Friday, June 23, 2006, a trademark application was filed for NULASTA with the United States Patent and Trademark Office. The USPTO has given the NULASTA trademark a serial number of 78916019. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 24, 2010. This trademark is owned by Amgen Inc.. The NULASTA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, pharmaceuticals for stimulating white blood cell production
nulasta

General Information

Serial Number78916019
Word MarkNULASTA
Filing DateFriday, June 23, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 24, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 30, 2007

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, pharmaceuticals for stimulating white blood cell production

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 29, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201789

Trademark Events

Event DateEvent Description
Monday, May 24, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 24, 2010ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 1, 2009EXTENSION 5 GRANTED
Thursday, August 27, 2009EXTENSION 5 FILED
Thursday, August 27, 2009TEAS EXTENSION RECEIVED
Monday, April 20, 2009EXTENSION 4 GRANTED
Thursday, April 16, 2009EXTENSION 4 FILED
Thursday, April 16, 2009TEAS EXTENSION RECEIVED
Monday, October 27, 2008EXTENSION 3 GRANTED
Wednesday, September 24, 2008EXTENSION 3 FILED
Monday, October 27, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 24, 2008TEAS EXTENSION RECEIVED
Thursday, April 17, 2008EXTENSION 2 GRANTED
Monday, March 31, 2008EXTENSION 2 FILED
Monday, March 31, 2008TEAS EXTENSION RECEIVED
Wednesday, October 3, 2007EXTENSION 1 GRANTED
Monday, September 24, 2007EXTENSION 1 FILED
Monday, September 24, 2007TEAS EXTENSION RECEIVED
Tuesday, April 24, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 30, 2007PUBLISHED FOR OPPOSITION
Wednesday, January 10, 2007NOTICE OF PUBLICATION
Saturday, December 9, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, December 9, 2006ASSIGNED TO LIE
Wednesday, November 22, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 20, 2006EXAMINER'S AMENDMENT ENTERED
Thursday, November 9, 2006EXAMINERS AMENDMENT E-MAILED
Thursday, November 9, 2006EXAMINERS AMENDMENT -WRITTEN
Monday, October 23, 2006NON-FINAL ACTION E-MAILED
Monday, October 23, 2006NON-FINAL ACTION WRITTEN
Friday, October 20, 2006ASSIGNED TO EXAMINER
Tuesday, September 26, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 29, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

nulasta blood cell production white stimulating preparations namely pharmaceuticals pharmaceutical